Literature DB >> 12923

Negative inotropic effect of lidocaine in patients with coronary arterial disease and normal subjects.

H Boudoulas, S F Schaal, R P Lewis, T G Welch, P DeGreen, R E Kates.   

Abstract

The effect of administration of lidocaine on left ventricular performance was studied using systolic time intervals in nine normal subjects, eight patients with stable angina, and 15 patients with acute myocardial infarction. The greatest response in systolic time intervals occurred at three minutes after intravenous injection of lidocaine (100 mg), with values returning to baseline at 10 to 15 minutes. Administration of lidocaine produced a significant prolongation of the preejection period (PEP) corrected for heart rate in all groups and a prolongation of the ratio of PEP to left ventricular ejection time (PEP/LVET) in patients with angina. The group with acute myocardial infarction exhibited a hyperadrenergic state, as shown by a short baseline QS2I. The QS I was lengthened by administration of lidocaine in all groups, but this was more profound in those with acute myocardial infarction. These changes in systolic time intervals were still present at two hours after injection in six patients with acute myocardial infarction in whom an infusion of lidocaine followed the initial bolus. The effect of administering lidocaine after intravenous injection of propranolol (5 mg) was also studied in six normal subjects. Although propranolol therapy along prolonged the PEP/LVET, a further significant prolongation followed subsequent injection of lidocaine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 12923     DOI: 10.1378/chest.71.2.170

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Changes in systolic time intervals-a non-invasive marker for the haemodynamic effects of sumatriptan.

Authors:  S Hood; D Birnie; L S Murray; P D MacIntyre; W S Hillis
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

2.  Are pre-ejection period changes specific for inotropic effects?

Authors:  P H Joubert; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

3.  Systolic time intervals in evaluation of the negative inotropic effect after single oral doses of mexiletine and disopyramide.

Authors:  D Rousson; C Piolat; J Galleyrand; S Ferry; J P Boissel
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Uncorrected pre-ejection period: a simple non-invasive measurement for pharmacodynamic screening of inotropic activity.

Authors:  D Rousson; J Galleyrand; M Silie; J P Boissel
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  Usefulness of the systolic time intervals in cardiovascular clinical cardiology.

Authors:  R P Lewis; H Boudoulas; C V Leier; D V Unverferth; A M Weissler
Journal:  Trans Am Clin Climatol Assoc       Date:  1982

6.  Effect of procainamide on left ventricular performance in patients with primary myocardial disease.

Authors:  P Geleris; H Boudoulas; S F Schaal; R P Lewis; J J Lima
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

Review 7.  Clinical pharmacokinetics of lignocaine.

Authors:  N L Benowitz; W Meister
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

Review 8.  The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.

Authors:  S Nattel; G Gagne; M Pineau
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

9.  Cardiac and microcirculatory effects of different doses of prostaglandin E1 in man.

Authors:  J H Wilkens; H Wilkens; B Elger; F Cassidy; L Caspary; A Creutzig; J C Frölich
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.